Canada markets open in 7 hours 57 minutes

Marker Therapeutics, Inc. (GX1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.6200-0.1000 (-2.69%)
At close: 08:14AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
466.785
-
Operating Expenses
Research Development
9,615
10,417
11,968
27,795
18,881
-
Selling General and Administrative
6,526
7,476
11,336
12,925
10,472
-
Total Operating Expenses
12,821
14,581
19,791
39,478
28,886
-
Operating Income or Loss
-12,821
-14,581
-19,791
-39,478
-28,419
-
Total Other Income/Expenses Net
-
-
-232.974
-2,407
31
18
Income Before Tax
-12,210
-14,042
-19,776
-41,879
-28,239
-
Income Tax Expense
-
3.675
0
-
-
-
Income from Continuing Operations
-12,214
-14,046
-19,776
-41,879
-28,706
-
Net Income
-5,662
-8,237
-29,931
-41,879
-28,706
-
Net Income available to common shareholders
-5,662
-8,237
-29,931
-41,879
-28,706
-
Basic EPS
-1.07
-0.94
-3.58
-5.47
-6.10
-
Diluted EPS
-1.08
-0.94
-3.58
-5.47
-6.10
-
Basic Average Shares
8,680
8,809
8,351
7,651
4,704
-
Diluted Average Shares
8,719
8,809
8,351
7,651
4,704
-